Retatrutide: Potential Availability of New Weight-Loss Drug Explored | Retatrutide News

Retatrutide is a weight-loss drug candidate from Eli Lilly, part of the GLP-1 agonists class. The article discusses its potential availability but lacks...
Market News · October 15, 2026